These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22411316)

  • 1. Caveolin-1 and prostate cancer progression.
    Freeman MR; Yang W; Di Vizio D
    Adv Exp Med Biol; 2012; 729():95-110. PubMed ID: 22411316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer.
    Moon H; Lee CS; Inder KL; Sharma S; Choi E; Black DM; Lê Cao KA; Winterford C; Coward JI; Ling MT; ; Craik DJ; Parton RG; Russell PJ; Hill MM
    Oncogene; 2014 Jul; 33(27):3561-70. PubMed ID: 23934189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
    Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
    J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.
    Nassar ZD; Hill MM; Parton RG; Parat MO
    Nat Rev Urol; 2013 Sep; 10(9):529-36. PubMed ID: 23938946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression.
    Gould ML; Williams G; Nicholson HD
    Prostate; 2010 Nov; 70(15):1609-21. PubMed ID: 20564315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression.
    Watanabe M; Yang G; Cao G; Tahir SA; Naruishi K; Tabata K; Fattah EA; Rajagopalan K; Timme TL; Park S; Kurosaka S; Edamura K; Tanimoto R; Demayo FJ; Goltsov AA; Thompson TC
    Mol Cancer Res; 2009 Sep; 7(9):1446-55. PubMed ID: 19737975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of caveolin-1 in androgen insensitive prostate cancer.
    Mouraviev V; Li L; Tahir SA; Yang G; Timme TM; Goltsov A; Ren C; Satoh T; Wheeler TM; Ittmann MM; Miles BJ; Amato RJ; Kadmon D; Thompson TC
    J Urol; 2002 Oct; 168(4 Pt 1):1589-96. PubMed ID: 12352463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.
    Di Vizio D; Morello M; Sotgia F; Pestell RG; Freeman MR; Lisanti MP
    Cell Cycle; 2009 Aug; 8(15):2420-4. PubMed ID: 19556867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor and caveolin-1 in prostate cancer.
    Bennett N; Hooper JD; Lee CS; Gobe GC
    IUBMB Life; 2009 Oct; 61(10):961-70. PubMed ID: 19787702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.
    Nasu Y; Timme TL; Yang G; Bangma CH; Li L; Ren C; Park SH; DeLeon M; Wang J; Thompson TC
    Nat Med; 1998 Sep; 4(9):1062-4. PubMed ID: 9734401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.
    Hammarsten P; Dahl Scherdin T; Hägglöf C; Andersson P; Wikström P; Stattin P; Egevad L; Granfors T; Bergh A
    PLoS One; 2016; 11(10):e0164016. PubMed ID: 27764093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor involvement in progression of prostate cancer.
    Russell PJ; Bennett S; Stricker P
    Clin Chem; 1998 Apr; 44(4):705-23. PubMed ID: 9554481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate.
    Bryant KG; Camacho J; Jasmin JF; Wang C; Addya S; Casimiro MC; Fortina P; Balasubramaniam S; Knudsen KE; Schwarting R; Lisanti MP; Mercier I
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1318-29. PubMed ID: 21601007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
    Karam JA; Lotan Y; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
    Prostate; 2007 May; 67(6):614-22. PubMed ID: 17299799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of extracellular delta-catenin accumulation for prostate cancer detection.
    Lu Q; Zhang J; Allison R; Gay H; Yang WX; Bhowmick NA; Frelix G; Shappell S; Chen YH
    Prostate; 2009 Mar; 69(4):411-8. PubMed ID: 19116988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canonical and Noncanonical Androgen Metabolism and Activity.
    Storbeck KH; Mostaghel EA
    Adv Exp Med Biol; 2019; 1210():239-277. PubMed ID: 31900912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC; Hooper JD; Johnson DW; Gobe GC
    Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
    Montgomery RB; Mostaghel EA; Vessella R; Hess DL; Kalhorn TF; Higano CS; True LD; Nelson PS
    Cancer Res; 2008 Jun; 68(11):4447-54. PubMed ID: 18519708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.